| non-REM | non-rapid eye movement [sleep] |
|---|---|
| NREM | nonrapid eye movement [sleep] |
| OD | Doctor of Optometry; obtained absorbance; occipital dysplasia; occupational dermatitis; occupational... |
| ol | left eye [Lat. oculus laevus] |
| OS | left eye [Lat. oculus sinister]; occipitosacral; occupational safety; office surgery; Omenn syndrome... |
| fluorescein eye examination | A special test that allows the examiner to detect cornea abrasions or corneal foreign bodies. An orange dye (fluorescein) is placed into the eye and the eye is illuminated with a cobalt blue light (black light). This serves to highlight any irregularities in the corneal surface. (27 Sep 1997) |
|---|---|
| lateral angle of eye | The angle formed by the junction of the lateral parts of the upper and lower eyelids. Synonym: angulus oculi lateralis, angulus oculi temporalis, external canthus, lateral canthus. (05 Mar 2000) |
| lazy eye | An eye that diverges in gaze. More formally called strabismus. Can be esotropia (cross-eyed) or exotropia (wall-eyed). (12 Dec 1998) |
| lens, eye | <microscopy> The lens in an eyepiece nearest to the eye. (05 Aug 1998) |
| light-adapted eye | An eye that has been exposed to light, with bleaching of rhodopsin (visual purple) and insensitivity to low illumination. Synonym: photopic eye. (05 Mar 2000) |
| Listing's reduced eye | A representation that simplifies calculations of retinal imagery: radius of anterior refracting surface, 5.1 mm; total length, 20 mm; distance of nodal point to retina, 15 mm. (05 Mar 2000) |
| acetyl-CoA:alpha-glucosaminide acetyltransferase | <enzyme> An enzyme involved in the synthesis of certain carbohydrate moieties on proteins. A deficiency of this enzyme leads to mucopolysaccharidosis type III C. (05 Mar 2000) |
| adrenergic alpha-agonists | Drugs that selectively bind to and activate alpha adrenergic receptors. (12 Dec 1998) |
| adrenergic alpha-antagonists | Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (12 Dec 1998) |
| alpha | First letter of the Greek alphabet, a. (05 Mar 2000) |
| alpha-1,3-mannosylglycoprotein beta-1,4-N-acetylglucosaminyltransferase | <enzyme> Incorporates n-acetyglucosamine as the third branch of complex n-glycosyl-oligosaccharide of hen oviduct Registry number: EC 2.4.1.145 Synonym: glcnac-transferase iv, n-acetylglucosaminyltransferase iv, udp-glcnac-gngn(glcnac to man alpha1-3)beta 4-n-acetylglucosaminyltransferase iv (26 Jun 1999) |
| alpha-1,4-glucan lyase | <enzyme> Degrades alpha-1,4-glucan to produce 1,5-anhydrofructose; from seaweeds gracilariopsis lemaneiformis and gracilaria verrucosa; mw 111 kD; amino acid sequence has been determined Registry number: EC 4.2.2.- Synonym: alpha-1,4-glucan 4-lyase (26 Jun 1999) |
| alpha 1-4-mannosyltransferase | <enzyme> From mycobacterium smegmatis; involved in methylmannose polysaccharide elongation; GDP-mannose is donor Registry number: EC 2.4.1.- (26 Jun 1999) |
| alpha(1-6)mannosidase | <enzyme> Human lysosomal enzyme highly specific for alpha 1-6 mannose residues; inhibited by swainsonine; not the same enzyme which is deficient in alpha-mannosidosis Registry number: EC 3.2.1.- (26 Jun 1999) |
| alpha 1,6-mannosyltransferase | <enzyme> From saccharomyces cerevisiae; adds mannose residues in an alpha-1,6-linkage to man8glcnac and man9glcnac in the biosynthesis of the outer chain of yeast mannoproteins Registry number: EC 2.4.1.- (26 Jun 1999) |